Oral insulin (Oshadi Drug Administration)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOral insulin (Oshadi Drug Administration)
Drug Alias NameOshadi Icp
ClassificationBiologics
Mechanisms of ActionReceptor protein-tyrosine kinase stimulantsOrnithine decarboxylase stimulants
TargetsReceptor protein-tyrosine kinaseOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOshadi Drug Administration
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A